Home›Companies›Biotech & Pharma›Solenic Medical

Solenic Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 15, 2024·Suggest an edit

About Solenic Medical

Solenic Medical is a private company based in College Station, Texas, incorporated in 2019 in Delaware. It has reported $9,602,498 raised in seven offerings on Form D since August 2019. Its chief executive is James Lancaster.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 29, 2024Mar 15, 2024$3,200,000of $4.0M target17$188KDebtRule 506(b), 4a5Form D ↗
Jan 22, 2024Feb 2, 2024$2,195,000of $4.0M target9$243KDebtRule 506(b), 4a5Form D ↗
Dec 14, 2022Dec 28, 2022$3,657,498of $7.0M target11$332KEquityRule 506(b)Form D ↗
Aug 8, 2022Aug 11, 2022$75,000of $500K target3$25,000Debt, Securities on exerciseRule 506(b)Form D ↗
May 19, 2021May 25, 2021$100,000of $1.0M target2$50,000Debt, Securities on exerciseRule 506(b)Form D ↗
May 15, 2020May 20, 2020$125,000of $500K target3$41,667Debt, OptionsRule 506(b)Form D ↗
Aug 5, 2019Aug 14, 2019$250,000fully sold1$250KEquityRule 506(b)Form D ↗
Total, seven offerings$9,602,498

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Solenic Medical's Form D filed Mar 15, 2024.

DG
David Greenberg
Chief Medical Officer
JL
James Lancaster
CEO & Director
CG
Calvin Goforth
Director
Also a director at Sfc Fluidics.
TM
Tamir Meiri
Director
JH
John Hodock
Director
RC
Rajiv Chopra
Chief Technology Officer & Director

Earlier filings also listed Mark Wagstaff (secretary, last listed Dec 2022), John Tepper (vice president of engineering and director, last listed Dec 2022), Robert Goforth (director, last listed Aug 2022) and R. Goforth (director, last listed Aug 2019).

Sources

  1. SECSolenic Medical, Inc. filing history